Telix Pharmaceuticals Limited (TLX)

Telix Pharmaceuticals Statistics

Total Valuation

TLX has a market cap or net worth of $3.94 billion. The enterprise value is $4.15 billion.

Market Cap	3.94B
Enterprise Value	4.15B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

TLX has 514.13 million shares outstanding. The number of shares has increased by 6.64% in one year.

Current Share Class	n/a
Shares Outstanding	514.13M
Shares Change (YoY)	+6.64%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	275.43M

Valuation Ratios

The trailing PE ratio is 363.48 and the forward PE ratio is 51.85.

PE Ratio	363.48
Forward PE	51.85
PS Ratio	5.93
Forward PS	n/a
PB Ratio	9.34
P/TBV Ratio	n/a
P/FCF Ratio	429.89
P/OCF Ratio	174.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 105.04, with an EV/FCF ratio of 452.49.

EV / Earnings	382.59
EV / Sales	6.25
EV / EBITDA	105.04
EV / EBIT	114.07
EV / FCF	452.49

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.99.

Current Ratio	1.33
Quick Ratio	1.11
Debt / Equity	0.99
Debt / EBITDA	10.19
Debt / FCF	45.62
Interest Coverage	2.04

Financial Efficiency

Return on equity (ROE) is 3.14% and return on invested capital (ROIC) is 4.04%.

Return on Equity (ROE)	3.14%
Return on Assets (ROA)	2.69%
Return on Invested Capital (ROIC)	4.04%
Return on Capital Employed (ROCE)	4.08%
Revenue Per Employee	$1.60M
Profits Per Employee	$26,131
Employee Count	415
Asset Turnover	0.79
Inventory Turnover	10.97

Taxes

Income Tax	-1.80M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	2.38
52-Week Price Change	n/a
50-Day Moving Average	14.68
200-Day Moving Average	n/a
Relative Strength Index (RSI)	31.58
Average Volume (20 Days)	97,721

Short Selling Information

The latest short interest is 48,849, so 0.01% of the outstanding shares have been sold short.

Short Interest	48,849
Short Previous Month	16,953
Short % of Shares Out	0.01%
Short % of Float	0.02%
Short Ratio (days to cover)	1.61

Income Statement

In the last 12 months, TLX had revenue of $664.23 million and earned $10.84 million in profits. Earnings per share was $0.03.

Revenue	664.23M
Gross Profit	358.28M
Operating Income	36.37M
Pretax Income	20.66M
Net Income	10.84M
EBITDA	39.50M
EBIT	36.37M
Earnings Per Share (EPS)	$0.03

Balance Sheet

The company has $207.16 million in cash and $418.25 million in debt, giving a net cash position of -$211.10 million or -$0.41 per share.

Cash & Cash Equivalents	207.16M
Total Debt	418.25M
Net Cash	-211.10M
Net Cash Per Share	-$0.41
Equity (Book Value)	421.94M
Book Value Per Share	0.82
Working Capital	99.43M

Cash Flow

In the last 12 months, operating cash flow was $22.63 million and capital expenditures -$22.47 million, giving a free cash flow of $9.17 million.

Operating Cash Flow	22.63M
Capital Expenditures	-22.47M
Free Cash Flow	9.17M
FCF Per Share	$0.02

Margins

Gross margin is 53.94%, with operating and profit margins of 5.48% and 1.63%.

Gross Margin	53.94%
Operating Margin	5.48%
Pretax Margin	1.36%
Profit Margin	1.63%
EBITDA Margin	5.95%
EBIT Margin	5.48%
FCF Margin	1.38%

Dividends & Yields

TLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.64%
Shareholder Yield	-6.64%
Earnings Yield	0.28%
FCF Yield	0.23%

Analyst Forecast

The average price target for TLX is $22.33, which is 103.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.33
Price Target Difference	103.56%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4